Medicon Hellas S.A. (MEDIC) - Total Liabilities

Latest as of December 2022: €14.85 Million EUR ≈ $17.37 Million USD

Based on the latest financial reports, Medicon Hellas S.A. (MEDIC) has total liabilities worth €14.85 Million EUR (≈ $17.37 Million USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Medicon Hellas S.A. (MEDIC) cash flow conversion to assess how effectively this company generates cash.

Medicon Hellas S.A. - Total Liabilities Trend (2014–2022)

This chart illustrates how Medicon Hellas S.A.'s total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Medicon Hellas S.A. to evaluate the company's liquid asset resilience ratio.

Medicon Hellas S.A. Competitors by Total Liabilities

The table below lists competitors of Medicon Hellas S.A. ranked by their total liabilities.

Company Country Total Liabilities
Zacatecas Silver Corp
V:ZAC
Canada CA$10.24 Million
PT Mitra Pack Tbk
JK:PTMP
Indonesia Rp104.19 Billion
Cambium Networks Corp
NASDAQ:CMBM
USA $175.62 Million
Esthetics International Group
KLSE:5081
Malaysia RM103.77 Million
Radius Gold Inc.
V:RDU
Canada CA$546.05K
Clemondo Group AB (publ)
ST:CLEM
Sweden Skr95.45 Million
Aban Offshore Limited
NSE:ABAN
India Rs285.19 Billion
MITCON Consultancy & Engineering Services Limited
NSE:MITCON
India Rs-1.40 Billion

Liability Composition Analysis (2014–2022)

This chart breaks down Medicon Hellas S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MEDIC market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio N/A Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medicon Hellas S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medicon Hellas S.A. (2014–2022)

The table below shows the annual total liabilities of Medicon Hellas S.A. from 2014 to 2022.

Year Total Liabilities Change
2022-12-31 €14.85 Million
≈ $17.37 Million
-11.84%
2021-12-31 €16.85 Million
≈ $19.70 Million
-4.17%
2020-12-31 €17.58 Million
≈ $20.56 Million
-3.76%
2019-12-31 €18.27 Million
≈ $21.36 Million
+4.20%
2018-12-31 €17.53 Million
≈ $20.50 Million
-23.18%
2017-12-31 €22.82 Million
≈ $26.68 Million
-15.15%
2016-12-31 €26.90 Million
≈ $31.45 Million
+4.74%
2015-12-31 €25.68 Million
≈ $30.02 Million
+2.22%
2014-12-31 €25.12 Million
≈ $29.37 Million
--

About Medicon Hellas S.A.

AT:MEDIC Greece Drug Manufacturers - Specialty & Generic
Market Cap
$13.28 Million
€11.36 Million EUR
Market Cap Rank
#26710 Global
#95 in Greece
Share Price
€2.57
Change (1 day)
-1.91%
52-Week Range
€2.28 - €2.87
All Time High
€5.07
About

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer sysytem for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It al… Read more